Fierce Pharma
SEPTEMBER 14, 2023
While there's certainly more work to do, the U.S. | Efforts from regulators and manufacturers have brought the U.S. supply of cisplatin back to nearly 100% of pre-shortage levels, according to the White House. The moves are “greatly alleviating the shortages of carboplatin,” too, the White House said.
MedCity News
SEPTEMBER 14, 2023
This week, senators introduced a bipartisan bill that would make it a federal crime to assault hospital workers. Even though nearly 40 states have passed laws to intensify penalties for violent acts committed against healthcare personnel, there is currently no federal law protecting hospital employees from assault or intimidation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 14, 2023
Alongside a new logo reveal Thursday, Johnson & Johnson unveiled some major changes to its corporate persona. | J&J is uniting its medtech and pharmaceutical arms so that they will be “more connected to the Johnson & Johnson brand," the company said. Over time, Janssen is slated to become Johnson & Johnson Innovate Medicine, while the company’s medical technology segment will continue to run with the J&J MedTech moniker.
MedCity News
SEPTEMBER 14, 2023
By making large amounts of diverse data widely available, healthcare institutions can feel confident about the evaluation, creation, and validation of algorithms as they’re transitioned from ideation to use.
Fierce Pharma
SEPTEMBER 14, 2023
Otsuka teamed up with Shape Therapeutics in an eye disease gene therapy deal potentially worth $1.5 billion. Astellas will build its third Irish manufacturing facility. | Otsuka teamed up with Shape Therapeutics in an eye disease gene therapy deal potentially worth $1.5 billion. Astellas will build its third Irish manufacturing facility for $354 million.
MedCity News
SEPTEMBER 14, 2023
Allogeneic cell therapy hasn’t caught up to autologous cell therapy yet, and the disappointing data so far has soured the entire allogeneic field for at least one venture capitalist. The cell therapy debate was one of the topics covered during a panel discussion at the Biopharm America conference.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
SEPTEMBER 14, 2023
MedImpact and GoodRx are teaming up to lower costs for MedImpact members. When eligible MedImpact members refill a generic prescription, the companies’ savings solution will compare the member’s benefit to GoodRx’s price and will automatically apply the lowest one.
Fierce Pharma
SEPTEMBER 14, 2023
Nearly seven years have passed since Alexion’s then-CEO and CFO stepped down amid an investigation into improper sales practices. | Alexion has reached a $125 million deal to settle a class action lawsuit brought by investors who lost money during a stock plunge caused by allegations about the company's sales practices for Soliris.
MedCity News
SEPTEMBER 14, 2023
When Medicaid expansion was first enacted, it was a hot topic debate between Democrats and Republicans. But more and more states are starting to expand Medicaid, including several conservative states.
Fierce Pharma
SEPTEMBER 14, 2023
By Dr Michael K Racke, Medical Director of Neurology, Quest Diagnostics | The escalating global challenge of Alzheimer's Disease (AD) demands new approaches to detection, diagnosis, and treatment. Dr. Racke will delve into recent advancements in the AD diagnostic landscape.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmExec
SEPTEMBER 14, 2023
Lung-I Cheng, vice president of cell and gene therapy (CGT), Cencora (formerly AmerisourceBergen), discusses CGT commercialization strategies, common knowledge gaps, and what he wishes companies knew about commercialization strategies.
Fierce Pharma
SEPTEMBER 14, 2023
A possible mutiny at Abcam?
European Pharmaceutical Review
SEPTEMBER 14, 2023
Under a new agreement, AstraZeneca is set to establish the first unsubsidised industrial-scale supply of biomethane. The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharma manufacturing site.
Medgadget
SEPTEMBER 14, 2023
Researchers at the University of California San Francisco have developed a brain computer interface that can lets someone with severe paralysis communicate with both speech and facial expressions, in the form of a digital avatar. The breakthrough advances what has been possible, with previous brain computer interface systems providing speech only, and allows people to communicate more completely, encompassing facial expressions, which are an important aspect of natural communication.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
European Pharmaceutical Review
SEPTEMBER 14, 2023
Rimegepant (Vydura) is the “first and only NICE-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment,” shared Helen Knight, Director of medicines evaluation at the National Institute for Health and Care Excellence (NICE). Made by Pfizer, Rimegepant (Vydura), is recommended in NICE final draft guidance for adults who have tried at least two triptans but failed to achieve adequate relief with these medicines.
Medgadget
SEPTEMBER 14, 2023
Researchers at the Harvard Wyss Institute have developed a technique that lets clinicians to characterize and monitor melanoma. The system involves using a microneedle patch that can draw deep interstitial fluid into itself through a series of penetrating hyaluronic acid needles. The needles can later be dissolved to release the biomarkers into a test tube before analysis, using a highly sensitive technique called Simoa, to detect individual biomarker protein molecules.
PharmaTech
SEPTEMBER 14, 2023
The companies are collaborating to apply ShapeTX’s AAVid capsid discovery platform and transgene engineering technology in addition to Otsuka’s expertise in genetic payload design and ophthalmology to develop novel treatment options for eye diseases.
MedCity News
SEPTEMBER 14, 2023
Even though providers and payers don’t always get along, they need to come together now more than ever. In the post-pandemic landscape, the healthcare industry won’t be able to maintain care quality and protect patient access without strong collaboration between these two parties, health system leaders said during a virtual panel.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Medgadget
SEPTEMBER 14, 2023
Researchers at the National University of Singapore have developed a highly sensitive pressure sensor that can provide haptic feedback for surgeons using laparoscopic tools or for use in robotic grippers as part of robotic surgical systems. The technology is inspired by the surface of the lotus leaf, which is extremely sensitive to the pressure exerted by tiny drops of water and will repel them.
Eversana Intouch
SEPTEMBER 14, 2023
Digital medicine is emerging as a revolutionary field that can transform the entire spectrum of healthcare, from proactive prevention to effective treatment of diverse medical conditions. Unlike traditional pharmaceutical medications, digital medicine products need to speak to the clinical, economic and technological benefits to differentiate themselves from competitors.
PharmaTimes
SEPTEMBER 14, 2023
The report highlights steps needed to ensure future pandemics are handled effectively - News - PharmaTimes
Contrarian Sales Techniques
SEPTEMBER 14, 2023
The Universal Truth Have you ever heard someone say, "I could never be in sales!"? It’s a sentiment many echo. Admittedly, the idea of selling for a living isn’t everyone's cup of tea. However, whether you're in the boardroom or at a family dinner, life often throws curveballs that require a bit of sales finesse. And here's the kicker: if you can master the art of selling, in many ways, you’re set for life.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PharmaTimes
SEPTEMBER 14, 2023
The funding will reduce waiting lists and ease the demand on the NHS during Winter - News - PharmaTimes
Pharmaceutical Technology
SEPTEMBER 14, 2023
Astellas Pharma is submitting a planning application for the construction of a new drug production facility in Ireland.
Penrod
SEPTEMBER 14, 2023
Over the last few months, you’ve learned lots about our core values! We have one more in store for you: Growth. Our five Core Values are: Accountability Flexibility Growth Grit Teamwork We define Growth as “Deliberate pursuit of improvement both on the individual and team level. We are all equally responsible for growth.” We’ve seen our folks display Growth by: Taking on new responsibilities and owning their success Stepping outside their comfort zone to learn something new Requesting, giving, a
LEVO Health
SEPTEMBER 14, 2023
In a healthcare landscape that’s more diverse than ever, the concept of one-size-fits-all is increasingly outdated. Physicians and other healthcare providers (HCPs) come from various disciplines, each with unique preferences, requirements, and pain points. Savvy healthcare marketers must now focus on tailored strategies that speak directly to the specific needs and preferences of HCPs.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Legacy MEDSearch
SEPTEMBER 14, 2023
Beacon Biosignals is thrilled to announce the milestone achievement of FDA 510(k) Clearance for the Dreem 3S, an advanced wearable headband with integrated machine learning algorithms to capture electroencephalogram (EEG) data from the brain to monitor sleep architecture and aid in the diagnosis of disturbed sleep. FDA Clearance marks it as equivalent to in-lab polysomnography for the assessment of sleep staging.
Rep-Lite
SEPTEMBER 14, 2023
In today’s rapidly changing business landscape, adaptability and efficiency are paramount. One solution that has gained immense popularity is the use of contract employees. They bring a range of benefits to the table, and when you partner with Rep-Lite , these advantages become even more pronounced. In this blog, we explore the numerous benefits of contract employees and how Rep-Lite can help you leverage these advantages to enhance your workforce.
Pharmaceutical Technology
SEPTEMBER 14, 2023
Ensuring equitable access to medicines is a key challenge for many governments, particularly those of smaller nations. Pharmaceutical Technology reviews the data and explores European initiatives to improve the situation.
Rep-Lite
SEPTEMBER 14, 2023
In the fast-paced world of business, speed can make all the difference, especially when it comes to hiring. Open positions represent opportunities, and the faster you can fill them, the sooner your organization can reap the benefits. This blog explores the numerous advantages of speed-to-hiring and how partnering with Rep-Lite can help you achieve your recruitment goals with efficiency and excellence.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
247 
Let's personalize your content